Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Emery

Showing results (61-70 of 586) with videos related to

Pageof 59
Sort By:
British Medical Journal (Clinical Research Ed.)|January 17, 1981
Adverse interaction between nifedipine and beta-blockadeJ S Staffurth, P Emery
British Medical Bulletin|April 1, 1995
The genetic origin of responses to drugsR H Waring, P Emery
Bailliere'S Clinical Rheumatology|February 1, 1997
What is early rheumatoid arthritis?: definition and diagnosisP Emery, D P Symmons
Clinical and Experimental Rheumatology|February 19, 2004
Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early interventionM A Quinn, P Emery
Arthritis and Rheumatism|December 1, 1988
Interleukin-2 inhibitor and measurement of interleukin-2 in synovial fluid of patients with rheumatoid arthritisP Emery, I R Mackay
Annals of the Rheumatic Diseases|January 1, 1988
Angioimmunoblastic lymphadenopathyP Emery, G S Panayi
Bailliere'S Clinical Rheumatology|June 1, 1992
Management of early inflammatory arthritis. Genetic factors predicting persistent disease: the role of defective enzyme systemsR H Waring, P Emery
Annals of the Rheumatic Diseases|October 30, 2003
Cyclosporin and methotrexate therapyP G Conaghan, P Emery
Rheumatology (Oxford, England)|September 23, 2000
Efficacy and safety of leflunomide in active rheumatoid arthritisJ S Smolen, P Emery
Journal of Paediatrics and Child Health|May 11, 1999
Camphor toxicityD P Emery, J G Corban
Pageof 59

Showing results (61-70 of 586) with videos related to

Sort By:
Pageof 59
British Medical Journal (Clinical Research Ed.)|January 17, 1981
Adverse interaction between nifedipine and beta-blockadeJ S Staffurth, P Emery
British Medical Bulletin|April 1, 1995
The genetic origin of responses to drugsR H Waring, P Emery
Bailliere'S Clinical Rheumatology|February 1, 1997
What is early rheumatoid arthritis?: definition and diagnosisP Emery, D P Symmons
Clinical and Experimental Rheumatology|February 19, 2004
Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early interventionM A Quinn, P Emery
Arthritis and Rheumatism|December 1, 1988
Interleukin-2 inhibitor and measurement of interleukin-2 in synovial fluid of patients with rheumatoid arthritisP Emery, I R Mackay
Annals of the Rheumatic Diseases|January 1, 1988
Angioimmunoblastic lymphadenopathyP Emery, G S Panayi
Bailliere'S Clinical Rheumatology|June 1, 1992
Management of early inflammatory arthritis. Genetic factors predicting persistent disease: the role of defective enzyme systemsR H Waring, P Emery
Annals of the Rheumatic Diseases|October 30, 2003
Cyclosporin and methotrexate therapyP G Conaghan, P Emery
Rheumatology (Oxford, England)|September 23, 2000
Efficacy and safety of leflunomide in active rheumatoid arthritisJ S Smolen, P Emery
Journal of Paediatrics and Child Health|May 11, 1999
Camphor toxicityD P Emery, J G Corban
Pageof 59